Michael A. Metzger - Mar 31, 2025 Form 4 Insider Report for Pyxis Oncology, Inc. (PYXS)

Role
Director
Signature
/s/ Pamela Connealy, Attorney-in-Fact for Michael A. Metzger
Stock symbol
PYXS
Transactions as of
Mar 31, 2025
Transactions value $
$36,239
Form type
4
Date filed
4/2/2025, 09:05 AM
Previous filing
Mar 17, 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PYXS Stock Option (Right to Buy) Award $36.2K +37K $0.98 37K Mar 31, 2025 Common Stock 37K $0.98 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to this option will vest 100% on the first anniversary of the grant date, subject to the reporting person's continued service through the applicable vesting date.